All In Biotech

Drug Trial Radar · NCT07938242

Comparison of Local Methylcobalamin and Subcutaneous Lidocaine in Subacute Herpetic Neuralgia

Comparison of Local Methylcobalamin Injection Versus Subcutaneous Lidocaine Injection in Patients With Subacute Herpetic Neuralgia

Last checked: Nov 20, 2026Latest source record: Nov 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

60

Planned (sponsor's estimate)

Start

Sep 1, 2026

Primary completion

Mar 1, 2027

Study completion Mar 1, 2027

Sponsor

Lead sponsor
CMH Multan Institute of Medical SciencesGovernment (non-federal)
Sponsor type
Government (non-federal)
First posted
Nov 16, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable
Allocation
Randomized
Model
Parallel
Masking
Single (outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
No
Who can join
All sexes, from 40 years, up to 70 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This randomized controlled trial will compare methylcobalamin and lidocaine injections for pain relief in 60 patients with subacute herpetic neuralgia over four weeks.

Conditions

  • Subacute Herpetic Neuralgia

Interventions

  • MethylcobalaminDrug

    Methylcobalamin injection (1 mg/2 mL) administered subcutaneously into up to four painful areas, with 0.5 mL injected at each area according to the patient's reported painful areas, six times per week for four weeks.

  • Injection lidocaineDrug

    Lidocaine inLidocaine injection (1%, 2 mL) administered subcutaneously into up to four painful areas, with 0.5 mL injected at each area according to the patient's reported painful areas, six times per week for four weeks.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pain scoreTime frame: Baseline (Day 1) and Day 28 (end of treatment).

Locations

1 site in 1 country. Site status is shown where the registry gives one.

  • Cmh Multan

    Multan, Punjab Province, Pakistan · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.